Hims vs Omnia TeleHealth
Hims and Omnia TeleHealth sell different medications; this is what separates them.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Hims
Best for: knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC
Visit Hims →
Omnia TeleHealth
Best for: coaching bundled into the price rather than sold separately
Visit Omnia TeleHealth →If you are choosing between Hims and Omnia TeleHealth, price alone will not settle it. Hims leads our six-part score, 6.8 to 6.1. One of the two has an FDA warning letter on record, covered below.
Hims vs Omnia TeleHealth price
Hims publishes $199 a month. Omnia TeleHealth does not post a GLP-1 price we can quote, so you would only learn its cost after an intake.
Medications and formats
Hims lists semaglutide and tirzepatide; Omnia TeleHealth does not name its drug.
On format, Hims prices compounded injections and brand-name pens, while Omnia TeleHealth posts no priced format.
If you want the FDA-approved brand rather than a compounded version, Hims is the only one of the two with a brand-name price.
Where each one treats patients
Hims lists 50 states, and Omnia TeleHealth does not publish where it ships.
Pricing
Hims
Brand Zepbound from $299/mo medication-only; requires Hims Weight Loss Membership ($149/mo)
Omnia TeleHealth
What each price covers
Hims' price also covers the medication itself, which Omnia TeleHealth does not claim.
Omnia TeleHealth's price also covers the clinician visit and coaching, which Hims does not claim.
Hims is silent on shipping and lab work.
That matters most for the drug: unless Omnia TeleHealth confirms otherwise, budget for medication on top of its listed price.
Hims
Covered by the monthly price
Medication
In the price
Clinician visits
Charged on top
Shipping
Not stated
Lab work
Not stated
Coaching
Charged on top
Omnia TeleHealth
Covered by the monthly price
Medication
Charged on top
Clinician visits
In the price
Shipping
Charged on top
Lab work
Charged on top
Coaching
In the price
Where each one scores higher
Overall, Hims scores 6.8 and Omnia TeleHealth 6.1 out of 10.
Hims is stronger on effectiveness (10.0 vs 9.0), trust & safety (7.0 vs 6.5) and accessibility (10.0 vs 5.0).
Omnia TeleHealth is stronger on support (4.0 vs 3.0).
Value and user experience are within half a point.
Hims
6.8/10
Omnia TeleHealth
6.1/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
The FDA sent Hims a warning letter dated September 9, 2025 (letter 716567), and it is still open.
Omnia TeleHealth has no FDA warning letter on record with us.
Features & Coverage
| Feature | Hims | Omnia TeleHealth |
|---|---|---|
| Starting Price | $199/mo | Not published |
| Features | 2 features | ✓8 features |
| States Available | 50 | Not disclosed |
| Compounded | ✓ Yes | — |
| Brand Name | ✓ Yes | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | 1 letter | ✓None |
About Hims
Hims is a major men's telehealth brand. Its weight loss offering is compounded semaglutide on a 6-month plan.
Read our full Hims review →About Omnia TeleHealth
The consultation is a flat $69 fee and no insurance is required. Omnia sells compounded semaglutide and tirzepatide for weight loss, with prescriptions coordinated through its compounding pharmacy partner Belmar Pharma Solutions or sent to any pharmacy nationwide. It was founded by Blair Carmichael-Lober, DNP, CRNP, and is LegitScript certified. The weight loss program pairs GLP-1 medication management with personalized nutrition guidance, exercise coaching and behavioral support across 17 US states.
Read our full Omnia TeleHealth review →Pros & Cons
Hims
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication
- Serves all 50 states
- Names 4 pharmacies that fill its prescriptions, which most sellers do not
Watch-outs
- Not included in the monthly price: clinician visits, coaching
- The FDA has issued Hims a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Omnia TeleHealth
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes clinician visits and coaching
- We found no FDA warning letters issued to Omnia TeleHealth
Watch-outs
- Not included in the monthly price: medication, shipping, lab work
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Our Verdict
Hims wins this one, 6.8 to 6.1, above all for knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC. Omnia TeleHealth fits better if coaching bundled into the price rather than sold separately is your priority.
Choose Hims if…
You want knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC and an opening price near $199 a month.
Choose Omnia TeleHealth if…
You want coaching bundled into the price rather than sold separately.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
bmiMD
Starting below a standard dose, with microdose tiers
From $99/mo
Get started →RxSpan MD
Knowing which pharmacy fills the vial: it names Belmar Pharmacy
From $249/mo
Get started →Luvo Health
Moving between compounded and brand without changing seller
From $249/mo
Get started →Hims vs Omnia TeleHealth: FAQ
Close alternatives to Hims and Omnia TeleHealth
- Hims vs Hers
- Hims vs Care Bare Rx
- Hims vs Concierge MD LA
- Hims vs Corsica Health
- Omnia TeleHealth vs Embody
- Omnia TeleHealth vs TrimRx
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.